王怡心

王怡心

[王怡心 @wang1130168]

Cost-effectiveness of Macrophage-Regulating Treatment for Wound Healing in Patients With DFUs
#ON101
#Fespixon
#footulcer
#wound
#dfu https://t.co/yeRtNKUR1J 來自 @JAMANetworkOpen part of @JAMANetwork

[王怡心 @wang1130168]

https://t.co/w6Iwd7zy42

#Bonvadis
#footulcer
#DFU

[王怡心 @wang1130168]

https://t.co/4YQQAKE8Ni

#Fespixon
#on101
#bonvadis

[王怡心 @wang1130168]

Fespixon（ON101) Promotes the Post-operative Scar Maturation and Remodeling

[JAMA Network Open @JAMANetworkOpen]

The economic value of adding ON101 into general wound care increased the number of healed events and patients’ quality-adjusted life years at the acceptable costs from a healthcare sector perspective in a Markov simulation model. https://t.co/ovwqFoeHBE

[王怡心 @wang1130168]

Validation of Fespixon in Postoperative Scar Cosmesis Using Quantitative Digital Photography Analysis

#ON101
#Fespixon https://t.co/H3xBdKLuBE

[王怡心 @wang1130168]

New Horizons of Macrophage Immunomodulation in the Healing of Diabetic Foot Ulcers https://t.co/CUNIBc0M2A #mdpipharmaceutics 來自 @MDPIpharma

#Fespixon
#ON101
#footulcer
#WDD
#WorldDiabetesDay
#DFU

[Tanner Pharma Group @TannerPharma]

#Fespixon is the world’s first drug to treat #diabetic foot ulcers. This program will enable more #DFU #patients in the world who would have otherwise gone without treatment to have access to this #medicine. #earlyaccess

Learn more: https://t.co/8tcAHMbApf

[JID Innovations @jidinnovations]

#JIDInnovations A plant-based topical might help heal diabetic foot ulcers by steering macrophages in the right direction https://t.co/tCS1VXDPFB #dermscience #dermtwitter @DiabetesUK @AmDiabetesAssn

[王怡心 @wang1130168]

Restoring Prohealing/Remodeling-Associated M2a/c Macrophages Using ON101 Accelerates Diabetic Wound Healing https://t.co/kp3JQ3QObi

#on101
#fespixon
#bonvadis
#footulcer
#diabetic
#wound

[王怡心 @wang1130168]

Restoring Pro-healing/remodeling- associated M2a/c Macrophages using O... https://t.co/Ss4rrTros4

#fespixon
#on101
#footulcer

[王怡心 @wang1130168]

490-P: Macrophage-Regulating Drug Promotes Tissue Proliferation in a DFU Real-World Case

#fespixon
#on101
https://t.co/cxE59xyn3w

[王怡心 @wang1130168]

Restoring Pro-healing/remodeling- associated M2a/c Macrophages using ON101 Accelerates Diabetic Wound Healing

#footulcer
#diabetic
#diabetes
https://t.co/ktPFzTjpyE

[王怡心 @wang1130168]

A Novel Macrophage-Regulating Drug for Wound Healing in Patients With Diabetic Foot Ulcers https://t.co/OXVBkh5o0k 來自 @JAMANetworkOpen part of @JAMANetwork

[王怡心 @wang1130168]

siRNA 靶向並抑制廣泛的 SARS-CoV-2 感染，包括 Delta 變體 | EMBO分子醫學 https://t.co/Cl824BLY9V
#COVID19
#SNS812
#siRNA
#Taiwan

[王怡心 @wang1130168]

A Novel Macrophage-Regulating Drug for Wound Healing in Patients With Diabetic Foot Ulcers https://t.co/7BefFIY67r 來自 @JAMANetworkOpen part of @JAMANetwork

[王怡心 @wang1130168]

Topical application of novel drug（fespixon,ON101） improved healing in patients with diabetic foot ulcers: JAMA https://t.co/ZnXXA4nNJe

[王怡心 @wang1130168]

New Cream Cures Foot Ulcers （Fespixon®） cream- Diabetes Self-Management https://t.co/k5RV0Dm5Md

[Diabetes Self-Mgmt @ManageDiabetes]

According to a report just published online in JAMA Network Open, a new topical cream has been shown to be dramatically effective in treating diabetic foot ulcers: https://t.co/ELLK37jp16

[Medscape Endo @MedscapeEndo]

Belgium's efforts to prioritize care at its diabetic foot ulcer clinics during the COVID-19 pandemic lockdown minimized both delays in care and adverse outcomes, new data suggest. https://t.co/fjP9FllV1F #EASD2021